The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota
Open accessAbstract
Summary Renal disease is growing in prevalence and has striking co-morbidities with metabolic and cardiovascular disease. Indoxyl sulfate (IS) is a toxin that accumulates in plasma when the kidney function declines and contributes to the progression of chronic kidney disease. IS derives exclusively from the gut microbiota. Bacterial tryptophanases convert tryptophan to indole, which is absorbed and modified by the host to produce IS. Here, we identify a widely distributed family of tryptophanases in the gut commensal Bacteroides and find that deleting this gene eliminates the production of indole in vitro. By altering the status or abundance of the Bacteroides tryptophanase, we can modulate IS levels in gnotobiotic mice and in the background of a conventional murine gut community. Our results demonstrate that it is possible to control host IS levels by targeting the microbiota and suggest a possible strategy for treating renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Clinical epidemiology of cardiovascular disease in chronic renal disease
Foley, R., Parfrey, P., & Sarnak, M. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,958
Holdeman, L. V., Moore, W. E., & Cato, E. P. (1977) · Cited by 2,988
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
Wikoff, W. R., Anfora, A. T., Liu, J., Schultz, P. G., Lesley, S. A., Peters, E. C., & Siuzdak, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812874106 · Cited by 2,677
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Rothhammer, V., Mascanfroni, I. D., Bunse, L., Takenaka, M. C., Kenison, J. E., Mayo, L., Chao, C.-C., Patel, B., Yan, R., Blain, M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4106 · Cited by 1,559
Glycan foraging in vivo by an intestine-adapted bacterial symbiont
Sonnenburg, J. L., Xu, J., Leip, D. D., Chen, C.-H., Westover, B. P., Weatherford, J., Buhler, J. D., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1109051 · Cited by 1,184
Self-citationIndole as an intercellular signal in microbial communities
Lee, J.-H., & Lee, J. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00204.x · Cited by 1,059
Normal and Pathologic Concentrations of Uremic Toxins
Duranton, F., Cohen, G., De Smet, R., Rodriguez, M., Jankowski, J., Vanholder, R., & Argiles, A. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121175 · Cited by 961
Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., & Massy, Z. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03980609 · Cited by 929
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Sonnenburg, E. D., Zheng, H., Joglekar, P., Higginbottom, S. K., Firbank, S. J., Bolam, D. N., & Sonnenburg, J. L. (2010) · Cell · doi:10.1016/j.cell.2010.05.005 · Cited by 748
Self-citationThe Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
PARFREY, P. S., & FOLEY, R. N. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1071606 · Cited by 653
p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease
Wu, I.-W., Hsu, K.-H., Lee, C.-C., Sun, C.-Y., Hsu, H.-J., Tsai, C.-J., Tzen, C.-Y., Wang, Y.-C., Lin, C.-Y., & Wu, M.-S. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq580 · Cited by 510
Meyer, T. W., & Hostetter, T. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071313 · Cited by 458
Self-citationUremic toxins originating from colonic microbial metabolism
Evenepoel, P., Meijers, B. K. I., Bammens, B. R. M., & Verbeke, K. (2009) · Kidney International · doi:10.1038/ki.2009.402 · Cited by 445
Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis.
Niwa, T., & Ise, M. (1994) · PubMed · Cited by 410
Commensal bacteria-dependent indole production enhances epithelial barrier function in the colon
Shimada, Y., Kinoshita, M., Harada, K., Mizutani, M., Masahata, K., Kayama, H., & Takeda, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080604 · Cited by 404
Kopple, J. D., Greene, T., Chumlea, W. C., Hollinger, D., Maroni, B. J., Merrill, D., Scherch, L. K., Schulman, G., Wang, S.-R., & Zimmer, G. S. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00014.x · Cited by 398
Oxidation of Indole by Cytochrome P450 Enzymes
Gillam, E. M. J., Notley, L. M., Cai, H., De Voss, J. J., & Guengerich, F. P. (2000) · Biochemistry · doi:10.1021/bi001229u · Cited by 313
The production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores
Patel, K. P., Luo, F. J.-G., Plummer, N. S., Hostetter, T. H., & Meyer, T. W. (2012) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12491211 · Cited by 226
Self-citationAdijiang, A., Goto, S., Uramoto, S., Nishijima, F., & Niwa, T. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm861 · Cited by 225
Niwa, T., Takeda, N., Tatematsu, A., & Maeda, K. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.11.2264 · Cited by 188
Uremic solutes from colon microbes
Meyer, T. W., & Hostetter, T. H. (2012) · Kidney International · doi:10.1038/ki.2011.504 · Cited by 180
Self-citationNiwa, T., Ise, M., & Miyazaki, T. (1994) · American Journal of Nephrology · doi:10.1159/000168716 · Cited by 178
Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate
Banoğlu, E., Jha, G. G., & King, R. J. (2001) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03226377 · Cited by 159
The Gut: The Forgotten Organ in Uremia?
Schepers, E., Glorieux, G., & Vanholder, R. C. (2010) · Blood Purification · doi:10.1159/000245639 · Cited by 152
Prominent Accumulation in Hemodialysis Patients of Solutes Normally Cleared by Tubular Secretion
Sirich, T. L., Funk, B. A., Plummer, N. S., Hostetter, T. H., & Meyer, T. W. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013060597 · Cited by 151
Self-citationCATALYTIC PROPERTIES OF TRYPTOPHANASE, A MULTIFUNCTIONAL PYRIDOXAL PHOSPHATE ENZYME
Newton, W. A., & Snell, E. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.3.382 · Cited by 143
Uremic toxicity of indoxyl sulfate.
Niwa, T. (2010) · PubMed · doi:10.18999/nagjms.72.1-2.1 · Cited by 139
Cato, E. P., & JOHNSON, J. L. (1976) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-26-2-230 · Cited by 125
Association of Indoxyl Sulfate with Heart Failure among Patients on Hemodialysis
Cao, X., Chen, J., Zou, J., Zhong, Y., Teng, J., Ji, J., Chen, Z., Liu, Z., Shen, B., Nie, Y., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04730514 · Cited by 122
The Prevalence of Species and Strains in the Human Microbiome: A Resource for Experimental Efforts
Kraal, L., Abubucker, S., Kota, K., Fischbach, M. A., & Mitreva, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097279 · Cited by 121
Self-citationShivanna, S., Kolandaivelu, K., Shashar, M., Belghasim, M., Al-Rabadi, L. F., Balcells, M., Zhang, A., Weinberg, J., Francis, J. M., Pollastri, M. P., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121241 · Cited by 113
Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate
Banoğlu, E., & King, R. S. (2002) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190428 · Cited by 103
Modification of cardiovascular risk in hemodialysis patients: An evidence‐based review
Johnson, D. W., Craven, A., & Isbel, N. M. (2007) · Hemodialysis International · doi:10.1111/j.1542-4758.2007.00146.x · Cited by 100
AST-120 Treatment in Pre-Dialysis Period Affects the Prognosis in Patients on Hemodialysis
Ueda, H., Shibahara, N., Takagi, S., Inoue, T., & Katsuoka, Y. (2008) · Renal Failure · doi:10.1080/08860220802356531 · Cited by 88
Indoxyl Sulfate Induces Nephrovascular Senescence
Niwa, T., & Shimizu, H. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2011.10.032 · Cited by 81
The Colon: An Overlooked Site for Therapeutics in Dialysis Patients
Poesen, R., Meijers, B. K. I., & Evenepoel, P. (2013) · Seminars in Dialysis · doi:10.1111/sdi.12082 · Cited by 80
Shoji, T., Wada, A., Inoue, K., Hayashi, D., Tomida, K., Furumatsu, Y., Kaneko, T., Okada, N., Fukuhara, Y., Imai, E., et al. (2006) · Nephron Clinical Practice · doi:10.1159/000097985 · Cited by 75
Kotarski, S. F., & Salyers, A. A. (1984) · Journal of Bacteriology · doi:10.1128/jb.158.1.102-109.1984 · Cited by 66
Nayfach, S., Fischbach, M. A., & Pollard, K. S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv382 · Cited by 60
Self-citationLombard, G. L., & Dowell, V. R. (1983) · Journal of Clinical Microbiology · doi:10.1128/jcm.18.3.609-613.1983 · Cited by 44
THE ROLE OF THE MICROBIAL FLORA IN UREMIA
Einheber, A., & Carter, D. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.2.239 · Cited by 42
THE ROLE OF THE MICROBIAL FLORA IN UREMIA
Carter, D., Einheber, A., Bauer, H., Rosen, H., & Burns, W. F. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.2.251 · Cited by 38
Cited by
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180
Microbial tryptophan catabolites in health and disease
Roager, H. M., & Licht, T. R. (2018) · Nature Communications · doi:10.1038/s41467-018-05470-4 · Cited by 2,236
Gut microbiota in cardiovascular health and disease
Tang, W. H. W., Kitai, T., & Hazen, S. L. (2017) · Circulation Research · doi:10.1161/circresaha.117.309715 · Cited by 1,670
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
Chemical transformation of xenobiotics by the human gut microbiota
Koppel, N., Maini Rekdal, V., & Balskus, E. P. (2017) · Science · doi:10.1126/science.aag2770 · Cited by 1,080
Metadata
- Authors
- Devlin, A. S., Marcobal, A., Dodd, D., Nayfach, S., Plummer, N., Meyer, T., Pollard, K. S., Sonnenburg, J. L., & Fischbach, M. A.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2016-12
- Volume
- 20
- Issue
- 6
- Pages
- 709-715
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2558941943
- Cited by
- 301
- References
- 45
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.